PubMed

Therapeutic use of Aldara in chronic myeloid leukemia.

Marleau AM, Lipton JH, Riordan NH, Ichim TE.

J Transl Med. 2007 Jan 25;5:4. Review.PMID: 17254347 [PubMed - indexed for MEDLINE]Related articlesFree article

Dynamics and potential impact of the immune response to chronic myelogenous leukemia.

Kim PS, Lee PP, Levy D.

PLoS Comput Biol. 2008 Jun 20;4(6):e1000095.PMID: 18566683 [PubMed - indexed for MEDLINE]Related articlesFree article

[Immunological evaluation for CML and its possibility for an immunotherapy]

Fujii S.

Nihon Rinsho Meneki Gakkai Kaishi. 2009 Aug;32(4):231-41. Japanese. PMID: 19721343 [PubMed - indexed for MEDLINE]Related articlesFree article

Dendritic cells from patients with chronic myeloid leukemia: functional and phenotypic features.

Eisendle K, Wolf D, Gastl G, Kircher-Eibl B.

Leuk Lymphoma. 2005 May;46(5):663-70. Review.PMID: 16019503 [PubMed - indexed for MEDLINE]Related articles

Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression.

Mumprecht S, Schürch C, Schwaller J, Solenthaler M, Ochsenbein AF.

Blood. 2009 Aug 20;114(8):1528-36. Epub 2009 May 6.PMID: 19420358 [PubMed - indexed for MEDLINE]Related articles

BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells.

Brauer KM, Werth D, von Schwarzenberg K, Bringmann A, Kanz L, Grünebach F, Brossart P.

Cancer Res. 2007 Jun 1;67(11):5489-97.PMID: 17545631 [PubMed - indexed for MEDLINE]Related articlesFree article

Targeted chronic myeloid leukemia therapy: seeking a cure.

Fausel C.

J Manag Care Pharm. 2007 Oct;13(8 Suppl A):8-12. Review.PMID: 17970609 [PubMed - indexed for MEDLINE]Related articlesFree article

Development and dynamics of robust T-cell responses to CML under imatinib treatment.

Chen CI, Maecker HT, Lee PP.

Blood. 2008 Jun 1;111(11):5342-9. Epub 2008 Mar 7.PMID: 18326818 [PubMed - indexed for MEDLINE]Related articlesFree article

[Effects of ST1571 on the development of dendritic cells derived from bone marrow mononuclear cells in patients with chronic myeloid leukemia]

Zheng SE, Jin J, Tong XM, Qian WB, Xue YQ.

Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):920-3. Chinese. PMID: 17533744 [PubMed - indexed for MEDLINE]Related articles

[An in vitro dendritic cells-induced T lymphocytes cytotoxicity study activated by thaw frozen K562 lysates antigen in chronic myeloid leukemia]

Zuo XL, Zhou X, Liu XH, Chen F, He L, Meng J, Qu XJ.

Zhonghua Nei Ke Za Zhi. 2006 Dec;45(12):1013-6. Chinese. PMID: 17327003 [PubMed - indexed for MEDLINE]Related articles

Evidence that a BCR-ABL fusion peptide does not induce lymphocyte proliferation or cytokine production in vitro.

Abu-Eisha HM, Butt NM, Clark RE, Christmas SE.

Leuk Res. 2007 Dec;31(12):1675-81. Epub 2007 Feb 26.PMID: 17324459 [PubMed - indexed for MEDLINE]Related articles

Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells.

Mumprecht S, Claus C, Schürch C, Pavelic V, Matter MS, Ochsenbein AF.

Blood. 2009 May 7;113(19):4681-9. Epub 2009 Feb 27.PMID: 19252140 [PubMed - indexed for MEDLINE]Related articles

Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.

Steinberg M.

Clin Ther. 2007 Nov;29(11):2289-308. Review.PMID: 18158072 [PubMed - indexed for MEDLINE]Related articles

BCR/ABL-specific CD8+ T cells can be detected from CML patients, but are only expanded from healthy donors.

Rusakiewicz S, Madrigal A, Travers P, Dodi AI.

Cancer Immunol Immunother. 2009 Sep;58(9):1449-57. Epub 2009 Apr 10.PMID: 19360407 [PubMed - indexed for MEDLINE]Related articles

Therapeutic potential of leukemia-derived dendritic cells: preclinical and clinical progress.

Claxton DF, McMannis J, Champlin R, Choudhury A.

Crit Rev Immunol. 2001;21(1-3):147-55. Review.PMID: 11642601 [PubMed - indexed for MEDLINE]Related articles

Leukemia-associated antigens as target structures for a specific immunotherapy in chronic myeloid leukemia.

Greiner J, Schmitt M.

Eur J Haematol. 2008 Jun;80(6):461-8. Epub 2008 Feb 12. Review.PMID: 18284627 [PubMed - indexed for MEDLINE]Related articles

Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.

Westermann J, Kopp J, van Lessen A, Hecker AC, Baskaynak G, le Coutre P, Döhner K, Döhner H, Dörken B, Pezzutto A.

Br J Haematol. 2007 May;137(4):297-306. Epub 2007 Apr 4.PMID: 17408402 [PubMed - indexed for MEDLINE]Related articles

The receptor for hyaluronic acid-mediated motility induces specific CD8+ T cell response in healthy donors and patients with chronic myeloid leukemia after allogeneic stem cell transplantation.

Chen J, Schmitt A, Bunjes D, Chen B, Schmitt M.

Int J Oncol. 2007 May;30(5):1119-27.PMID: 17390013 [PubMed - indexed for MEDLINE]Related articles

Targeted drugs in chronic myeloid leukemia.

Gora-Tybor J, Robak T.

Curr Med Chem. 2008;15(29):3036-51. Review.PMID: 19075651 [PubMed - indexed for MEDLINE]Related articles

[Clinico-immunologic effect of tactivin in chronic myeloid leukemia]

Abdulkadyrov KM, Guseva SA.

Gematol Transfuziol. 1994 Sep-Oct;39(5):19-22. Russian. PMID: 7896024 [PubMed - indexed for MEDLINE]Related articles